Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Volume 18, 2017 - Issue sup1: Edaravone (MCI-186) in Amyotrophic Lateral Sclerosis (ALS). Guest Editor: Angela Genge
Submit an article Journal homepage
4,580
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Introduction to supplement: the current status of treatment for ALS

Robert G. MillerForbes Norris ALS Treatment and Research Center, California Pacific Medical Center, San Francisco, CA, USA and Correspondence[email protected]
&
Stanley H. AppelEdwards Distinguished Endowed Chair for ALS Research; Chair, Department of Neurology; Co-Director, Houston Methodist Neurological Institute, Houston, TX, USA
Pages 1-4 | Received 17 May 2017, Accepted 17 Jul 2017, Published online: 05 Sep 2017

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.